These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24873015)

  • 1. [Statins in CIN: a problem at least partly solved?].
    Andreucci M
    G Ital Nefrol; 2013; 30(3):. PubMed ID: 24873015
    [No Abstract]   [Full Text] [Related]  

  • 2. Additional data supporting the use of statins to prevent contrast induced nephropathy.
    Pappy R; Abu-Fadel MS
    Int J Cardiol; 2011 Oct; 152(2):265-6. PubMed ID: 21872353
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
    Wu H; Li D; Fang M; Han H; Wang H
    J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Loading Dose of Atorvastatin for the Prevention of Serum Creatinine and Cystatin C-Based Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention.
    Fu N; Liang M; Yang S
    Angiology; 2018 Sep; 69(8):692-699. PubMed ID: 29343076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Dose of Atorvastatin for the Treatment of Contrast-Induced Nephropathy After Carotid Artery Stenting.
    Fu M; Dai W; Ye Y; Lu Q; He W
    Am J Ther; 2017; 24(6):e718-e722. PubMed ID: 26720167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of statins in preventing contrast-induced nephropathy: an updated meta-analysis.
    Xie H; Ye Y; Shan G; Zhang S; Fang Q; Yang D; Zeng Y
    Coron Artery Dis; 2014 Nov; 25(7):565-74. PubMed ID: 25036858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The PRATO-ACS study].
    Marenzi G; Briguori C
    G Ital Cardiol (Rome); 2013 Dec; 14(12):803-8. PubMed ID: 24336595
    [No Abstract]   [Full Text] [Related]  

  • 9. Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression.
    He X; Li L; Tan H; Chen J; Zhou Y
    J Pharmacol Sci; 2016 May; 131(1):18-27. PubMed ID: 27156929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Statins in Preventing Contrast-Induced Acute Kidney Injury: A Narrative Review.
    Akyuz S; Yaylak B; Altay S; Kasikcioglu H; Cam N
    Angiology; 2015 Sep; 66(8):701-7. PubMed ID: 25192700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for Prevention of Contrast-Associated Acute Kidney Injury: Is the Debate a Moot Point?
    Bangalore S
    Cardiovasc Revasc Med; 2019 Aug; 20(8):632-633. PubMed ID: 31420072
    [No Abstract]   [Full Text] [Related]  

  • 12. Statins and contrast-induced acute kidney injury.
    Briguori C; Napolitano G; Condorelli G
    Coron Artery Dis; 2014 Nov; 25(7):550-1. PubMed ID: 25248137
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
    Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
    Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins use and the risk of acute kidney injury: a meta-analysis.
    Mao S; Huang S
    Ren Fail; 2014 May; 36(4):651-7. PubMed ID: 24502671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-induced acute kidney injury in diabetes mellitus: Clinical relevance and predisposing factors. Could statins be of benefit?
    Katsiki N; Fonseca V; Mikhailidis DP
    J Diabetes Complications; 2018 Nov; 32(11):982-984. PubMed ID: 30131213
    [No Abstract]   [Full Text] [Related]  

  • 16. HMG-CoA enzyme inhibitors for prevention of contrast-induced nephropathy.
    Briasoulis A; Afonso L
    J Thromb Thrombolysis; 2014 Nov; 38(4):457-8. PubMed ID: 24832462
    [No Abstract]   [Full Text] [Related]  

  • 17. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
    Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
    Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of complications after percutaneous coronary interventions with statins].
    Mega S; Nusca A; Patti G
    Recenti Prog Med; 2012 Jan; 103(1):5-10. PubMed ID: 22322620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials.
    Barbieri L; Verdoia M; Schaffer A; Nardin M; Marino P; De Luca G
    J Thromb Thrombolysis; 2014 Nov; 38(4):493-502. PubMed ID: 24705677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro.
    He X; Yang J; Li L; Tan H; Wu Y; Ran P; Sun S; Chen J; Zhou Y
    Mol Med Rep; 2017 Apr; 15(4):1963-1972. PubMed ID: 28260077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.